Table 3: Infant mortality, EID, and mother-to-child
transmission of rates.
|
Observed parameters |
Urban |
Rural |
Total |
p |
|||
|
Number of infants (loss to
follow up or dead or utilization of services) |
% dead of infants, access to
tests and mother to child transmission rates |
Number of infants (loss to
follow up or dead or utilization of services) |
% dead of infants, access to
tests and mother to child transmission rates |
Number of infants (loss to
follow up or dead or utilization of services) |
% dead of infants, access to
tests and mother to child transmission rates |
||
|
All newborn |
366 |
‡ |
233 |
‡ |
599 |
‡ |
|
|
Stillbirth |
4 |
1.1 |
0 |
0.0 |
4 |
0.7 |
0.31 |
|
Alive births |
362 |
98.9 |
233 |
100.0 |
595 |
99.3 |
0.31 |
|
Nevirapine at birth |
362 |
100.0 |
233 |
100.0 |
595 |
100.0 |
‡ |
|
HIV exposed infants lost to follow up |
28 |
7.7 |
41 |
17.6 |
69 |
11.6 |
0.04 |
|
Deaths of HIV exposed infants before PCR test (6-10 weeks of age) |
1 |
0.3 |
2 |
1.0 |
3 |
0.6 |
0.53 |
|
EID tests at 6-10 weeks of age |
92 |
27.6 |
16 |
8.4 |
108 |
20.7 |
< 0.001 |
|
EID tests at 12 months |
|
|
|
|
|
|
‡ |
|
HIV infected infants at 6-10 weeks of age |
2 |
2.2 |
2 |
12.5 |
4 |
3.7 |
0.003 |
|
Infant mortality between 10 weeks and 12 months of age |
11 |
3.3 |
19 |
10.0 |
30 |
5.7 |
0.03 |
|
Infant HIV positive at 12 months of age |
22 |
6.8 |
15 |
8.8 |
37 |
7.5 |
0.79 |
‡: not calculated